Literature DB >> 17464142

Sustained low-efficiency dialysis.

Ashita J Tolwani1, Thomas S Wheeler, Keith M Wille.   

Abstract

Sustained low-efficiency dialysis (SLED) is an increasingly popular form of renal replacement therapy for patients with renal failure in the intensive care unit. Advantages of SLED are efficient clearance of small solutes, good hemodynamic tolerability, flexible treatment schedules, and reduced costs. Studies comparing outcomes of SLED with those of other dialysis modalities are being performed.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17464142     DOI： 10.1159/000102122

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


  5 in total

Review 1.  Prolonged intermittent renal replacement therapy in children.

Authors:  Rajiv Sinha; Sidharth Kumar Sethi; Timothy Bunchman; Valentine Lobo; Rupesh Raina
Journal:  Pediatr Nephrol       Date:  2017-07-18       Impact factor: 3.714

Review 2.  Pediatric renal replacement therapy in the intensive care unit.

Authors:  Brian C Bridges; David J Askenazi; Jessimene Smith; Stuart L Goldstein
Journal:  Blood Purif       Date:  2012-10-24       Impact factor: 2.614

3.  Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients.

Authors:  Abdulla K Salahudeen; Vikas Kumar; Niti Madan; Lianchun Xiao; Amit Lahoti; Joshua Samuels; Joseph Nates; Kristen Price
Journal:  Clin J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 8.237

4.  Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis.

Authors:  Ambar Khaira; Ankur Gupta; Devendra S Rana; Ashwini Gupta; Anil Bhalla; Dinesh Khullar
Journal:  Int Urol Nephrol       Date:  2009-04-30       Impact factor: 2.370

5.  Sustained low-efficiency daily diafiltration for diabetic nephropathy patients with acute kidney injury.

Authors:  Xinghua Chen; Te'an Ma
Journal:  Med Princ Pract       Date:  2014-01-23       Impact factor: 1.927
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.